Kraig Biocraft Laboratories (KBLB) Total Liabilities (2016 - 2022)
Kraig Biocraft Laboratories (KBLB) has disclosed Total Liabilities for 11 consecutive years, with $8.8 million as the latest value for Q3 2022.
- Quarterly Total Liabilities fell 4.98% to $8.8 million in Q3 2022 from the year-ago period, while the trailing twelve-month figure was $8.8 million through Sep 2022, down 4.98% year-over-year, with the annual reading at $8.3 million for FY2021, N/A changed from the prior year.
- Total Liabilities hit $8.8 million in Q3 2022 for Kraig Biocraft Laboratories, down from $9.2 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $9.2 million in Q3 2021 to a low of $3.7 million in Q1 2018.
- Historically, Total Liabilities has averaged $6.7 million across 4 years, with a median of $6.9 million in 2019.
- Biggest five-year swings in Total Liabilities: soared 34.31% in 2019 and later fell 4.98% in 2022.
- Year by year, Total Liabilities stood at $4.5 million in 2018, then grew by 21.49% to $5.5 million in 2019, then soared by 51.12% to $8.3 million in 2021, then grew by 5.52% to $8.8 million in 2022.
- Business Quant data shows Total Liabilities for KBLB at $8.8 million in Q3 2022, $9.2 million in Q2 2022, and $8.7 million in Q1 2022.